• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD 6.90% 2.7¢

ADALTA LIMITED

AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company... AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II clinical trials with applications in the fields of inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic for the treatment of fibrotic diseases, including lung fibrosis (specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD)), kidney fibrosis, eye fibrosis and some cancers. Chimeric Antigen Receptor (CAR) cell therapies involve modification of a patient’s immune cells (T cells, NK cells, macrophages and other) so that they produce a CAR on the cell surface that enables the patient’s immune system to recognize and kill diseased cells such as cancer. It develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology. It evaluates several CXCR4 i-bodies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 04/05/24 22 3.4K
04/05/24 Last post  Sammyn123 Comments Created with Sketch.  22  Views Created with Sketch.  3.4K 
1AD
Significant growth funding webinar recording
02/05/24 0 161
02/05/24 Last post  kranski1977 Comments Created with Sketch.  0  Views Created with Sketch.  161 
1AD 01/05/24 0 131
01/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  131 
1AD 30/04/24 12 2.6K
30/04/24 Last post  FXm Comments Created with Sketch.  12  Views Created with Sketch.  2.6K 
1AD 30/04/24 4 754
30/04/24 Last post  debono Comments Created with Sketch.  4  Views Created with Sketch.  754 
1AD 30/04/24 0 130
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  130 
1AD
News: 1AD Adalta Secures Up To A$3.7 Million To Pursue Strategic Initiatives
29/04/24 0 136
29/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  136 
1AD 29/04/24 0 131
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  131 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - 1AD
01 May 09:52
 
Investor webinar presentation
01 May 09:48
 
Application for quotation of securities - 1AD
30 Apr 10:02
 
Investor webinar
30 Apr 08:30
 
Cleansing Notice under Section 708A
29 Apr 08:59
 
Cleansing Notice under Section 708A
29 Apr 08:59
 
View More arrow Created with Sketch.
(20min delay)
Last
2.7¢
Change
-0.002(6.90%)
Mkt cap ! $14.38M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $9.445K 348.8K

Buyers (Bids)

No. Vol. Price($)
1 21405 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 681148 3
View Market Depth
Last trade - 13.13pm 03/05/2024 (20 minute delay) ?
Last
2.7¢
  Change
-0.002 ( 3.57 %)
Open High Low Volume
2.7¢ 2.7¢ 2.7¢ 269805
Last updated 13.13pm 03/05/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.